|
|
|
|
| LEADER |
00000nam a2200000 i 4500 |
| 001 |
mig00005944014 |
| 003 |
OCoLC |
| 005 |
20210304110643.0 |
| 006 |
m o d f |
| 007 |
cr ||||||||||| |
| 008 |
210304s2021 dcuab ob f000 0 eng d |
| 035 |
0 |
0 |
|a on1240422157
|
| 040 |
|
|
|a GPO
|b eng
|e rda
|e pn
|c GPO
|d MvI
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a TXME
|
| 074 |
|
|
|a 0546-D-01 (online)
|
| 086 |
0 |
|
|a GA 1.5/2:GAO-21-409 T
|
| 099 |
|
|
|a Online Government Document
|
| 110 |
1 |
|
|a United States.
|b Government Accountability Office,
|e author.
|
| 245 |
1 |
0 |
|a Drug safety: FDA's future inspection plans need to address issues presented by COVID-19 backlog :
|b testimony before the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations, House of Representatives /
|c statement of Mary Denigan-Macauley.
|
| 246 |
3 |
|
|a Drug safety: Food and Drug Administration's future inspection plans to address issues presented by COVID-19 backlog
|
| 264 |
|
1 |
|a [Washington, D.C.] :
|b United States Government Accountability Office,
|c 2021.
|
| 300 |
|
|
|a 1 online resource (18 pages) :
|b color illustrations, color map.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Testimony ;
|v GAO-21-409T
|
| 500 |
|
|
|a "For release on delivery, expected at 10:00 a.m. ET, Thursday, March 4, 2021."
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 588 |
|
|
|a Description based on online resource, PDF version; title from cover (GAO, viewed Mar. 3, 2021).
|
| 610 |
1 |
0 |
|a United States.
|b Food and Drug Administration
|x Rules and practice.
|
| 650 |
|
0 |
|a COVID-19 (Disease)
|x Treatment
|z United States.
|
| 650 |
|
0 |
|a COVID-19 Pandemic, 2020-
|z United States.
|
| 650 |
|
0 |
|a Drugs
|x Inspection
|z United States.
|
| 650 |
|
0 |
|a Drugs
|z United States
|x Safety measures.
|
| 650 |
|
0 |
|a Drug reimportation
|z United States.
|
| 700 |
1 |
|
|a Denigan-Macauley, Mary,
|e author.
|
| 710 |
1 |
|
|a United States.
|b Congress.
|b House.
|b Committee on Appropriations.
|b Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies,
|e sponsoring body.
|
| 830 |
|
0 |
|a Testimony ;
|v GAO-21-409T.
|
| 856 |
4 |
0 |
|z CONNECT
|u https://purl.fdlp.gov/GPO/gpo152288
|t 0
|
| 907 |
|
|
|a 5379772
|b 06-10-21
|c 05-06-21
|
| 998 |
|
|
|a wi
|b 05-06-21
|c m
|d z
|e -
|f eng
|g dcu
|h 0
|i 1
|
| 910 |
|
|
|a MTSUM April 2021
|
| 910 |
|
|
|a DWS
|
| 999 |
f |
f |
|i c5ac7608-6b87-466a-b5aa-90e5c72a9204
|s f547324c-d29c-45c8-9b29-3f0c0da33cf5
|t 0
|
| 952 |
f |
f |
|a Middle Tennessee State University
|b Main
|c James E. Walker Library
|d Electronic Resources
|t 0
|e GA 1.5/2:GAO-21-409 T
|h Library of Congress classification
|
| 856 |
4 |
0 |
|t 0
|u https://purl.fdlp.gov/GPO/gpo152288
|z CONNECT
|
